Bekkers, C. H. J., Touw, D. J., Lamers, C. B. H. W., & Geus, W. P. (2002). The effect of CYP2C19 polymorphism on the pharmacokinetics and acid-inhibitory effects of oral lansoprazole and omeprazole. Blackwell Science Inc.
Citación estilo ChicagoBekkers, C H J., D J. Touw, C B H W. Lamers, and W P. Geus. The Effect of CYP2C19 Polymorphism On the Pharmacokinetics and Acid-inhibitory Effects of Oral Lansoprazole and Omeprazole. Blackwell Science Inc, 2002.
Cita MLABekkers, C H J., D J. Touw, C B H W. Lamers, and W P. Geus. The Effect of CYP2C19 Polymorphism On the Pharmacokinetics and Acid-inhibitory Effects of Oral Lansoprazole and Omeprazole. Blackwell Science Inc, 2002.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.